A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
Conditions: Advanced Solid Tumor; Breast Neoplasms Interventions: Drug: BPI-1178; Drug: Fulvestrant; Drug: Letrozole Sponsor: Beta Pharma (Suzhou) Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials